MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 70 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,316 | -25.9% | 32,089 | 0.0% | 0.00% | – |
| Q2 2023 | $348,487 | +57.4% | 32,089 | 0.0% | 0.00% | – |
| Q1 2023 | $221,414 | +172879.7% | 32,089 | 0.0% | 0.00% | – |
| Q4 2022 | $128 | -100.0% | 32,089 | -56.9% | 0.00% | – |
| Q2 2022 | $360,000 | -56.4% | 74,511 | -15.7% | 0.00% | – |
| Q1 2022 | $826,000 | -21.3% | 88,385 | 0.0% | 0.00% | – |
| Q4 2021 | $1,050,000 | +100.0% | 88,385 | +91.6% | 0.00% | – |
| Q3 2021 | $525,000 | -67.1% | 46,131 | -48.1% | 0.00% | -100.0% |
| Q2 2021 | $1,595,000 | +69.5% | 88,907 | +46.1% | 0.00% | – |
| Q1 2021 | $941,000 | +22.0% | 60,848 | -3.7% | 0.00% | – |
| Q4 2020 | $771,000 | +76.8% | 63,217 | +85.8% | 0.00% | – |
| Q3 2020 | $436,000 | – | 34,029 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $41,305,000 | 7.74% |
| VR Adviser, LLC | 2,641,809 | $30,064,000 | 3.86% |
| Bleichroeder LP | 1,062,500 | $12,091,000 | 1.96% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $16,285,000 | 1.01% |
| Boxer Capital, LLC | 2,400,000 | $27,312,000 | 0.95% |
| 683 Capital Management, LLC | 1,929,929 | $21,963,000 | 0.86% |
| Avoro Capital Advisors LLC | 3,235,000 | $36,814,000 | 0.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,197,426 | $25,007,000 | 0.42% |
| Granite Point Capital Management, L.P. | 419,324 | $4,772,000 | 0.36% |
| KNOTT DAVID M | 81,166 | $924,000 | 0.34% |